Related Experiment Videos
Sentinel lymph node navigation surgery for pancreatic head cancers
Tetsuo Ohta1, Hirohisa Kitagawa, Masato Kayahara
1Department of Gastroenterologic Surgery, Kanazawa University Hospital, Kanazawa 920-0934, Japan. ohtat@surg2.m.kanazawa-u.ac.jp
Oncology Reports
|February 13, 2003
Summary
Sentinel lymph node (SN) biopsy for pancreatic cancer helps identify key drainage sites. This approach allows avoiding extensive lymph node dissection, reducing patient morbidity and potentially improving survival rates.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Cancer Research
Background:
- Sentinel lymph node (SN) concept is established for various cancers.
- The No. 13 lymph node group is a primary drainage site for pancreatic head tumors.
- SN status predicts No. 16 lymph node involvement, crucial for surgical staging.
Purpose of the Study:
- To develop and evaluate SN navigation surgery for pancreatic cancer.
- To determine if SN biopsy can guide surgical decisions for lymph node dissection.
- To assess the impact of SN biopsy on curability, morbidity, and survival.
Main Methods:
- Patent blue dye injected into peritumoral area to identify SNs in the No. 13 lymph node group.
- Intraoperative frozen section of identified SNs.
- Decision-tree based on SN status: extended No. 16 dissection avoided if SNs are negative.
Main Results:
- SNs identified in 89% of patients (8/9).
- Extended No. 16 lymph node dissection was avoided in 4 SN-negative patients.
- Overall 3-year survival rate was 36%; 4 patients with Stage IVa disease survived 3 years.
Conclusions:
- SN biopsy is feasible and effective in pancreatic cancer surgery.
- SN-guided surgery can reduce morbidity by avoiding unnecessary extensive lymph node dissection.
- This approach offers a potential alternative for improving curability and long-term survival in locally advanced pancreatic head cancer.